# Alan Sokolow

> Alan Sokolow is a startup investor at Prognos Health (New York). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Prognos Health](https://shizune.co/investors/profile/prognos-health-fb63)
- Location: New York, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/alan-sokolow-2b2a573

Alan Sokolow is a startup investor at Prognos Health in New York. Dr. Sokolow has a unique career in healthcare, having been involved early in the development of healthcare informatics, and program development in demand and care management. His areas of expertise include value-based reimbursement, medical policy, medical management, high risk and condition management programs, provider relations and programimplementation.With Oxford, Dr. Sokolow was instrumental in the development of ETG based analyses of health care costs, as well as the pioneering design of case based contracting. At Empire Alan was responsible for refining transactional systems alerts, which led to systematic improvement in quality care. He has repeatedly lead teams in various engagements, which implemented high risk case management programs based on predictive models, resulting in significant cost savings and reduction in hospitalization. He is an expert in medical cost management.Dr. Sokolow graduated from Pomona College and UCLA School of Medicine. He trained in Internal Medicine at the University of Utah, and at the University of Rochester. Board certified in Internal Medicine.

## About Prognos Health

VC Fund · New York, United States

Prognos Health is a leading health tech company that is pushing the boundaries of healthcare analytics. The company’s platform, prognosFACTOR, has the power to query billions of lab and health records on more than 325 million de-identified patients to answer clinically-focused healthcare questions in minutes, not months. The platform enables thequerying and purchasing of patient-centric, HIPAA-Compliant healthcare data from the Prognos Marketplace to address diverse applications, including cohort design, patient journey studies, health outcomes and more. Customers include 25 of the top 30 pharmaceutical manufacturers and three of the top five payers.

5 contacts available at Prognos Health.

| Name | Title | Profile |
| --- | --- | --- |
| Alan Sokolow | Board Advisor | https://shizune.co/investors/profile/alan-sokolow |
| Alan Sokolow | Board Advisor | https://shizune.co/investors/profile/alan-e-sokolow-md |
| Adam Petranovich | Chief Data Scientist | https://shizune.co/investors/profile/adam-petranovich |
| Cathy Wong | VP, Corporate Strategy | https://shizune.co/investors/profile/cathy-wong |
| Daniel Berlinger | VP, Engineering, Data & IT | https://shizune.co/investors/profile/daniel-berlinger |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co